- List
- By Topic
- On Map
- Search Details

Recruiting, Not yet recruiting, Available Studies | "Bacterial Infections"
Need help? See RSS Feeds
Choose a feed type:

Recruiting, Not yet recruiting, Available Studies | "Bacterial Infections" (655 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT02688790 | Recruiting | Study Evaluate the PK Profile of Dalbavancin in Hospitalized Infants and Neonates Patients With Known or Suspected Bacterial Infection |
|
|
Interventional | Phase 1 |
|
Industry |
|
|
12 | All | up to 28 Days (Child) | NCT02688790 | DAL-PK-02 | April 1, 2016 | May 1, 2020 | May 1, 2020 | February 23, 2016 | July 6, 2017 |
|
||
2 | NCT02794831 | Not yet recruiting | Exposure to NSAIDs (Non Steroidal Anti-Inflammatory Drugs) and Severity of Community-acquired Bacterial Infections |
|
Observational |
|
Other |
|
|
300 | All | 18 Years and older (Adult, Senior) | NCT02794831 | RC15_0364 | ANAIG | June 2016 | June 2019 | June 2019 | June 9, 2016 | June 9, 2016 | ||||
3 | NCT02687906 | Recruiting | Dose-finding, Pharmacokinetics, Safety, and Tolerability of VABOMERE (Meropenem-Vaborbactam) in Pediatric Subjects With Serious Bacterial Infections |
|
|
Interventional | Phase 1 |
|
Industry / U.S. Fed |
|
|
60 | All | up to 17 Years (Child) | NCT02687906 | Rempex 507 | TANGOKIDS | July 2016 | August 2019 | September 2019 | February 22, 2016 | March 22, 2018 |
|
|
4 | NCT02134301 | Recruiting | Open-Label, Dose-Finding, Pharmacokinetics, Safety and Tolerability Study of Oritavancin in Pediatric Patients With Suspected or Confirmed Bacterial Infections |
|
|
Interventional | Phase 1 |
|
Industry |
|
|
52 | All | up to 18 Years (Child, Adult) | NCT02134301 | TMC-ORI-11-01 | May 2014 | December 2018 | June 2019 | May 9, 2014 | March 12, 2018 |
|
||
5 | NCT03225079 | Recruiting | PERFORM = Pentaglobin® Registry For Outcome Report and Monitoring |
|
Observational |
|
Other |
|
|
400 | All | 18 Years and older (Adult, Senior) | NCT03225079 | ZKSJ0103_PERFORM | PERFORM | November 8, 2017 | June 2020 | June 2021 | July 21, 2017 | November 30, 2017 |
|
|||
6 | NCT02760745 | Recruiting | Fever and Shivering: Frequency and Role in Predicting Serious Bacterial Infection |
|
|
Observational |
|
Other |
|
|
200 | All | 3 Months to 18 Years (Child, Adult) | NCT02760745 | ASF-0207-15 | January 2016 | November 2016 | December 2016 | May 4, 2016 | November 15, 2016 |
|
|||
7 | NCT02750761 | Recruiting | A Study of Oral and Intravenous (IV) Tedizolid Phosphate in Hospitalized Participants, Ages 2 to <12 Years, With Confirmed or Suspected Bacterial Infection (MK-1986-013) |
|
|
Interventional | Phase 1 |
|
Industry |
|
|
32 | All | 2 Years to 11 Years (Child) | NCT02750761 | 1986-013 TR701-120 2015-004595-29 |
May 2, 2016 | March 23, 2019 | March 23, 2019 | April 25, 2016 | April 18, 2018 |
|
||
8 | NCT03397433 | Recruiting | ANti-infective Stewardship Using the Wisca Tool in the Electronic Medical Record |
|
|
Interventional | Not Applicable |
|
Other |
|
|
6000 | All | 18 Years and older (Adult, Senior) | NCT03397433 | EH13-368 | ANSWER | June 2015 | July 2018 | October 2018 | January 12, 2018 | January 12, 2018 |
|
|
9 | NCT03204591 | Not yet recruiting | Bacterial Infections in Cirrhotic Patients With Acute Severe Liver Injury |
|
|
Observational |
|
Other |
|
|
500 | All | Child, Adult, Senior | NCT03204591 | NSFC81670567 | July 20, 2017 | October 18, 2018 | January 18, 2019 | July 2, 2017 | July 2, 2017 | ||||
10 | NCT03369951 | Recruiting | Minocycline PK (ACUMIN) |
|
|
Interventional | Phase 4 |
|
NIH |
|
|
67 | All | 18 Years to 99 Years (Adult, Senior) | NCT03369951 | 16-0011 5UM1AI104681-06 |
February 7, 2018 | January 31, 2019 | January 31, 2019 | December 12, 2017 | March 30, 2018 |
|
||
11 | NCT03475472 | Recruiting New |
Direct Molecular Characterization of Bacteria From ICU |
|
Observational |
|
Other |
|
|
1560 | All | Child, Adult, Senior | NCT03475472 | 2018-00049 | me17Khanna2 | February 1, 2018 | January 31, 2020 | January 31, 2021 | March 23, 2018 | March 23, 2018 |
|
|||
12 | NCT03450187 | Recruiting | A Phase 1 TP-271 Oral PK Multiple Ascending Dose Study |
|
|
Interventional | Phase 1 |
|
Industry / NIH |
|
|
40 | All | 18 Years to 50 Years (Adult) | NCT03450187 | TP-271-004 | March 20, 2018 | August 2018 | January 2019 | March 1, 2018 | April 6, 2018 |
|
||
13 | NCT03424525 | Recruiting | 11C-Trimethoprim PET/CT Imaging to Evaluate Biodistribution and Kinetics in Human Subjects |
|
|
Interventional | Phase 1 |
|
Other |
|
|
30 | All | 18 Years and older (Adult, Senior) | NCT03424525 | 827333 | February 1, 2018 | November 2019 | November 2019 | February 7, 2018 | April 11, 2018 |
|
||
14 | NCT02837081 | Recruiting | Preauthorization Versus Prospective Audit in Antimicrobial Stewardship Program |
|
|
Interventional | Not Applicable |
|
Other |
|
|
1060 | All | 20 Years and older (Adult, Senior) | NCT02837081 | VGHKS15-CT12-05 | December 2015 | December 2016 | March 2017 | July 19, 2016 | July 19, 2016 |
|
||
15 | NCT02598141 | Recruiting | Grinding Versus Standard Methods for the Treatment of Per-operative Bacteriological Samples Associated With Osteo-articular Sepsis |
|
|
Interventional | Not Applicable |
|
Other |
|
|
122 | All | 18 Years and older (Adult, Senior) | NCT02598141 | LOCAL/2015/NC-01 2015-A00720-49 |
IOAP Turrax | May 2016 | November 2017 | November 2017 | November 5, 2015 | May 24, 2016 |
|
|
16 | NCT02436876 | Recruiting | Study to Assess Safety and Clinical Activity of Local MBN-101 in Treatment of Infected Bone Sites |
|
|
Interventional | Phase 2 |
|
Industry / Other / U.S. Fed |
|
|
24 | All | 18 Years to 75 Years (Adult, Senior) | NCT02436876 | MBN-101-201 W81XWH-12-2-0100 |
January 2016 | June 2018 | July 2018 | May 7, 2015 | November 13, 2017 |
|
||
17 | NCT02527681 | Recruiting | Pharmacokinetics and Safety of Ceftobiprole in Neonates and Infants up to 3 Months Treated With Systemic Antibiotics |
|
|
Interventional | Phase 1 |
|
Industry |
|
|
45 | All | up to 3 Months (Child) | NCT02527681 | BPR-PIP-001 2013-004614-18 |
November 2016 | December 2018 | December 2018 | August 19, 2015 | January 31, 2018 |
|
||
18 | NCT01611740 | Recruiting | Contribution of Real Time Analyses of CARdio-RESpiratory Signals to the Diagnosis of Infection in PREterM Infants |
|
|
Observational |
|
Other |
|
|
500 | All | 24 Weeks to 32 Weeks (Child) | NCT01611740 | 2011-A00324-37 | CARESS_PREMI | May 2012 | November 2017 | January 2018 | June 5, 2012 | August 29, 2017 |
|
||
19 | NCT03266341 | Not yet recruiting | Detection of Anaerobes in Different Clinicalsamples |
|
|
Observational |
|
Other |
|
|
100 | All | Child, Adult, Senior | NCT03266341 | Anaerobes detection in samples | September 15, 2017 | November 2019 | December 2019 | August 30, 2017 | September 1, 2017 | ||||
20 | NCT03299894 | Recruiting | Impact of qSOFA Calculation on the Timing of Antimicrobial Therapy in the Emergency Department |
|
|
Interventional | Not Applicable |
|
Other |
|
|
780 | All | 18 Years to 105 Years (Adult, Senior) | NCT03299894 | CHRO 2017-06 | qSOFAST | November 29, 2017 | March 29, 2019 | March 29, 2019 | October 3, 2017 | December 4, 2017 |
|
|
21 | NCT03016845 | Recruiting | Pharmacokinetics of Ciprofloxacin in Critically Ill Patients |
|
Observational |
|
Other |
|
|
40 | All | 18 Years and older (Adult, Senior) | NCT03016845 | UMCN-AFK 16.07 | CAPOEIRA | January 1, 2017 | March 2018 | April 2018 | January 11, 2017 | November 17, 2017 |
|
|||
22 | NCT02993575 | Recruiting | Pharmacokinetics of Flucloxacillin Given by Continuous or Intermittent Infusion to ICU Patients |
|
|
Observational |
|
Other |
|
|
30 | All | 18 Years and older (Adult, Senior) | NCT02993575 | UMCN-AKF-16.08 | FANATIC | June 1, 2017 | March 2018 | April 2018 | December 15, 2016 | November 17, 2017 |
|
||
23 | NCT02753387 | Recruiting | Effect of Oral Preparation on Bacterial Colonization of the Pharyngeal Mucosa in Surgery of Head and Neck Cancer |
|
|
Interventional | Phase 3 |
|
Other |
|
|
80 | All | 18 Years and older (Adult, Senior) | NCT02753387 | 35RC15_8923_ORAL-ISO | ORAL-ISO | May 23, 2016 | November 23, 2018 | February 23, 2019 | April 27, 2016 | April 11, 2018 |
|
|
24 | NCT02962934 | Not yet recruiting | An Observational Pharmacokinetic Sudy of Ceftolozane-Tazobactam in Intensive Care Unit in Patients With and Without CRRT |
|
|
Observational |
|
Other |
|
|
18 | All | 18 Years and older (Adult, Senior) | NCT02962934 | Royal_Brisbane | CT-PK | November 2016 | November 2018 | December 2018 | November 15, 2016 | November 15, 2016 | |||
25 | NCT02666274 | Recruiting | Feasibility Studies to Inform Novel Proposals to Avert Community-Based Antimicrobial Resistance Spread |
|
Observational |
|
Other |
|
|
45 | All | 18 Years and older (Adult, Senior) | NCT02666274 | RJ115/N354 | December 2015 | January 2017 | June 2017 | January 28, 2016 | November 28, 2016 |
|
||||
26 | NCT02117986 | Recruiting | Efficacy and Mortality of a Loading Dose of Colistin in Critical Ill Patients |
|
|
Interventional | Phase 4 |
|
Other |
|
|
200 | All | 18 Years and older (Adult, Senior) | NCT02117986 | SA13I20317 | April 2014 | December 2018 | December 2018 | April 21, 2014 | March 13, 2018 |
|
||
27 | NCT02013141 | Recruiting | Telavancin Pediatric PK Study (Ages >3 Months to 17 Years) |
|
|
Interventional | Phase 4 |
|
Industry |
|
|
36 | All | 3 Months to 17 Years (Child) | NCT02013141 | 0101 | December 2014 | September 2020 | October 2020 | December 17, 2013 | April 17, 2018 |
|
||
28 | NCT03053258 | Recruiting | Diagnostic Breath Analysis for Detection of Ventilator Acquired Pneumonia (VAP) |
|
|
Observational |
|
Other |
|
|
50 | All | 18 Years and older (Adult, Senior) | NCT03053258 | Study 177 ZNose | VAP-VOC | October 2016 | October 2018 | February 2019 | February 15, 2017 | April 10, 2018 |
|
||
29 | NCT02553083 | Recruiting | High Dose Dual Therapy (HDDT) for Eradication of Helicobacter Pylori Infection |
|
|
Interventional | Phase 4 |
|
Other |
|
|
300 | All | 18 Years to 80 Years (Adult, Senior) | NCT02553083 | 0380-15-RMC | HDDT | October 22, 2015 | September 2020 | December 2021 | September 17, 2015 | January 31, 2018 |
|
|
30 | NCT02898948 | Recruiting | Procalcitonin (PCT) as a Diagnostic Marker of Bacterial Infection in the Patients Admitted for Fever and/or Inflammatory Syndrome to the Internal Medicine Department |
|
|
Observational |
|
Other |
|
|
133 | All | 18 Years and older (Adult, Senior) | NCT02898948 | RNI2015-38 Dr Schmidt | PCT-MI | February 2016 | August 2018 | August 2018 | September 13, 2016 | September 13, 2016 |
|
||
31 | NCT03160040 | Recruiting | A Retrospective Observational Study to Evaluate the Utilization, Outcomes, and Adverse Events in Participants Treated With Minocin® (Minocycline) for Infections Caused by Gram-negative Bacteria in a Real World Setting |
|
|
Observational |
|
Industry |
|
|
100 | All | 18 Years and older (Adult, Senior) | NCT03160040 | MDCO-MIN-16-05 | October 11, 2017 | April 1, 2018 | April 1, 2018 | May 19, 2017 | March 5, 2018 |
|
|||
32 | NCT00945152 | Recruiting | Effects of MRSA Bactericidal Gel To Promote Healing and Eliminate MRSA in cSSTI Vancogel(TM) |
|
|
Interventional | Phase 2 |
|
Other |
|
|
100 | All | 18 Years and older (Adult, Senior) | NCT00945152 | WIRB study # 1111446 None yet, self funding |
Vancogel(R) | July 2011 | December 2018 | December 2018 | July 23, 2009 | August 30, 2017 |
|
|
33 | NCT02164409 | Recruiting | Changes Associated With H. Pylori and Gastric Carcinogenesis |
|
|
Observational |
|
Other |
|
|
120 | All | 18 Years and older (Adult, Senior) | NCT02164409 | 1203012274 | IIT H pylori | July 2012 | December 2018 | December 2018 | June 16, 2014 | December 4, 2017 |
|
||
34 | NCT02931526 | Recruiting | Study of Tigecycline Pharmacokinetics in Patients Undergoing Continuous Renal Replacement Therapy(CRRT) |
|
|
Observational |
|
Other |
|
|
20 | All | 18 Years to 75 Years (Adult, Senior) | NCT02931526 | LCYJ1 | August 2016 | August 2017 | October 13, 2016 | October 13, 2016 |
|
||||
35 | NCT02914132 | Recruiting | Safety Evaluation of Seraph® 100 to Reduce Bacteremia in Patients on Hemodialysis |
|
|
Interventional | Not Applicable |
|
Industry |
|
|
15 | All | 18 Years to 90 Years (Adult, Senior) | NCT02914132 | CP001 | February 2016 | May 2018 | July 2018 | September 26, 2016 | February 1, 2018 |
|
||
36 | NCT03230916 | Recruiting | A Pharmacokinetics Study of MK-7655A in Pediatric Participants With Gram-negative Infections (MK-7655A-020) |
|
|
Interventional | Phase 1 |
|
Industry |
|
|
44 | All | up to 17 Years (Child) | NCT03230916 | 7655A-020 2016-004328-43 |
November 6, 2017 | August 13, 2020 | August 13, 2020 | July 27, 2017 | April 18, 2018 |
|
||
37 | NCT01338116 | Recruiting | Optimal Antibiotic Treatment of Moderate to Severe Bacterial Infections |
|
|
Interventional | Phase 3 |
|
Other |
|
|
600 | All | 18 Years and older (Adult, Senior) | NCT01338116 | 6036 | CDSS | April 2016 | January 2018 | January 2019 | April 19, 2011 | April 7, 2016 |
|
|
38 | NCT03233438 | Recruiting | Development of a New Critical Pathway for Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) |
|
|
Interventional | Phase 4 |
|
Industry |
|
|
86 | All | 18 Years and older (Adult, Senior) | NCT03233438 | CMO-US-ID-0528 | July 24, 2017 | June 30, 2018 | June 30, 2018 | July 28, 2017 | August 23, 2017 |
|
||
39 | NCT01892358 | Recruiting | Preventing Bacterial and Viral Infections Among Injection Drug Users |
|
|
Interventional | Not Applicable |
|
Other |
|
|
350 | All | 18 Years to 75 Years (Adult, Senior) | NCT01892358 | DA034957 1210-003 |
September 2013 | January 2019 | January 2019 | July 4, 2013 | April 12, 2018 |
|
||
40 | NCT02655302 | Not yet recruiting | Study of the Involvement of IL-17 / IL-22 Pathway in Bacterial Exacerbations of COPD |
|
|
Interventional | Not Applicable |
|
Other |
|
|
100 | All | 40 Years and older (Adult, Senior) | NCT02655302 | 2013_76 2015-A00190-49 |
COPD1722 | September 2017 | December 2022 | December 2022 | January 14, 2016 | June 7, 2017 |
|
|
41 | NCT02572791 | Recruiting | Staph Household Intervention for Eradication (SHINE) |
|
|
Interventional | Phase 4 |
|
Other |
|
|
207 | All | up to 18 Years (Child, Adult) | NCT02572791 | 3177 60559 | SHINE | October 2015 | January 2020 | July 2020 | October 9, 2015 | March 20, 2018 |
|
|
42 | NCT03431766 | Recruiting | 0.2% Chx Gel vs Implant Bacterial Contamination |
|
|
Interventional | Not Applicable |
|
Other |
|
|
36 | All | 18 Years to 75 Years (Adult, Senior) | NCT03431766 | 2342 | November 17, 2015 | January 12, 2019 | June 30, 2019 | February 13, 2018 | February 13, 2018 |
|
||
43 | NCT03243864 | Recruiting | Study of Ceftazidime-Avibactam Blood Concentrations in Intensive Care Unit Patients With Renal Failure Requiring Continuous Dialysis |
|
|
Observational |
|
Other / Industry |
|
|
10 | All | 18 Years and older (Adult, Senior) | NCT03243864 | 866 | March 13, 2017 | March 21, 2019 | October 21, 2019 | August 9, 2017 | August 9, 2017 |
|
|||
44 | NCT02814916 | Recruiting | Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
300 | All | 3 Months to 17 Years (Child) | NCT02814916 | DUR001-306 2014-005281-30 |
March 30, 2017 | January 25, 2019 | January 25, 2019 | June 28, 2016 | June 7, 2017 |
|
||
45 | NCT03438214 | Not yet recruiting | Effect of Intermittent Infusion Versus Continuous Infusion of Vancomycin on Kidney Failure in Critically Ill Patients |
|
|
Interventional | Phase 4 |
|
Other |
|
|
222 | All | 18 Years and older (Adult, Senior) | NCT03438214 | 81226617.8.1001.0065 | ETERNITY | April 28, 2018 | February 28, 2020 | December 1, 2022 | February 19, 2018 | April 5, 2018 |
|
|
46 | NCT03163628 | Recruiting | biomArkers to differeNtiate bacTerial From vIral iNfEctions |
|
|
Interventional | Not Applicable |
|
Other |
|
|
800 | All | up to 36 Months (Child) | NCT03163628 | 69HCL16_0799 | ANTOINE | June 6, 2017 | June 13, 2019 | June 13, 2019 | May 23, 2017 | July 14, 2017 |
|
|
47 | NCT03367897 | Recruiting | Bleeding Ulcer and Erosions Study "BLUE Study" |
|
Observational |
|
Other |
|
|
600 | All | 18 Years and older (Adult, Senior) | NCT03367897 | 1319 | BLUE | March 2015 | December 2017 | July 2018 | December 11, 2017 | December 11, 2017 |
|
|||
48 | NCT03271580 | Recruiting | Biofilm Modified Macrophage Phenotype and Function in Diabetic Wound Healing |
|
|
Observational |
|
Other |
|
|
28 | All | 18 Years to 70 Years (Adult, Senior) | NCT03271580 | 2017H0010 | February 5, 2017 | February 5, 2018 | August 1, 2018 | September 5, 2017 | September 5, 2017 |
|
|||
49 | NCT03088111 | Not yet recruiting | An Open Label Field Study of Anthim (Obiltoxaximab) in Subjects Exposed to B. Anthracis |
|
|
Interventional | Phase 4 |
|
Other / U.S. Fed / Industry |
|
|
100 | All | Child, Adult, Senior | NCT03088111 | AH501 HHSO100201100034C |
January 1, 2020 | January 1, 2021 | January 1, 2021 | March 23, 2017 | January 9, 2018 | |||
50 | NCT03132246 | Recruiting | MICRO Study: Detecting Bacterial Infections Related to Orthopaedic Surgical Implants |
|
|
Interventional | Not Applicable |
|
Other |
|
|
500 | All | 18 Years and older (Adult, Senior) | NCT03132246 | HP-00055743 | MICRO | April 2014 | July 2018 | July 2018 | April 27, 2017 | January 19, 2018 |
|
† Study has passed its completion date and status has not been verified in more than two years.